Feasibility and efficacy of 223Ra-dichloride in treatment of bone metastases in patients with castration-refractory prostate cancer (mCRPC)

被引：0
|
作者：
Mazzarri, S. [1 ]
Boni, G. [1 ]
Borso, E. [2 ]
Galli, L. [3 ]
Farnesi, A. [3 ]
Betti, F. [1 ]
Antonacci, L. [1 ]
Traino, A. [4 ]
Ricci, S. [3 ]
Volterrani, D. [1 ]
机构：
[1] Univ Hosp Pisa, Reg Ctr Nucl Med, Pisa, Italy
[2] SantAndrea Hosp La Spezia, Div Nucl Med, La Spezia, Italy
[3] Univ Hosp Pisa, Div Oncol, Pisa, Italy
[4] Univ Hosp, Sect Med Phys, Hlth Phys Unit, Pisa, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP136
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [1] Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC)
    Farnesi, A.
    Mazzarri, S.
    Boni, G.
    Galli, L.
    Cianci, C.
    Borso', E.
    Marconcini, R.
    Biasco, E.
    Derosa, L.
    Sbrana, A.
    Antonuzzo, A.
    Ricci, S.
    Volterrani, D.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 62 - 62
  • [2] Early experience with 223Ra-dichloride treatment of prostate cancer patients with multiple bone metastases
    Santha, O.
    Szegedi, J.
    Garai, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S742 - S742
  • [3] Radium-223 dichloride in patients with castration-refractory prostate cancer
    Winter, B. M.
    von Rundstedt, F. -C.
    Grimm, M. -O.
    UROLOGE, 2017, 56 (11): : 1435 - 1439
  • [4] 223Ra-dichloride Treatment In mCRPC Patients: Analysis Of An Elderly Population
    Frantellizzi, V.
    Sollaku, S.
    Pontico, M.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S568 - S568
  • [5] 223Ra-dichloride response in a patient with Paget disease and bone metastases secondary to castration-resistant prostate cancer
    Garcia Canamaque, Lina
    Rioja Parada, Cristina
    Garcia de la Pena, Paloma
    TUMORI, 2017, 103 : S53 - S55
  • [6] Response to 223Ra-dichloride in castration-resistant prostate cancer with bone metastasis: A case report
    Estorch Cabrera, Montserrat
    Maroto Rey, Pablo
    Carrio, Ignasi
    Montes, Alberto
    Alonso Lopez, Diego
    ONCOLOGY LETTERS, 2016, 12 (02) : 1323 - 1328
  • [7] Compartmental model for 223Ra-Dichloride in Patients with metastatic bone disease from castration-resistant prostate cancer
    Taprogge, J.
    Murray, I.
    Flux, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S807 - S808
  • [8] Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer
    Taprogge, Jan
    Murray, Iain
    Gear, Jonathan
    Chittenden, Sarah J.
    Parker, Christopher C.
    Flux, Glenn D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (04): : 884 - 892
  • [9] Use Of 223Ra-dichloride In Mcrpc Patients At The Early Onset Of Castration Resistance: Is Early Introduction Useful?
    Frantellizzi, V.
    De Feo, M. S.
    Lazri, J.
    Cosma, L.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S236 - S236
  • [10] 223Ra-Dichloride therapy for castrate-resistant prostate cancer osseous metastases
    Marcus, Charles
    Subramaniam, Rathan
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
12345